Actions of Vibrio vulnificus metalloprotease on human plasma proteinase- proteinase inhibitor systems: A comparative study of native protease with its derivative modified by polyethylene glycol

Shin-ichi Miyoshi, H. Narukawa, K. I. Tomochika, S. Shinoda

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Vibrio vulnificus, an opportunistic human pathogen causing wound infection and septicemia, produces a metalloprotease (VVP) which is suspected to be a virulent determinant. The interactions of VVP, as well as its derivative (PEG1-VVP) modified with polyethylene glycol, with a variety of human plasma proteins were investigated. We found that native VVP and its derivative were able to act directly on many biologically important human plasma proteins even in the presence of α-macroglobulin, the sole plasma inhibitor of native VVP. The activities of both classical and alternative pathways of the complement cascade system were drastically abolished by incubation with either VVP. Furthermore, these proteases rapidly digested the Aα-chain of human fibrinogen into fragment(s) with no clotting ability. Therefore both VVPs are thought to function as a fibrinogenolytic enzyme, causing delay of the coagulation reaction. VVP and PEG1-VVP were also shown to destroy plasma proteinase inhibitors including α1-proteinase inhibitor, a major inhibitor in human plasma. Because endogenous proteolytic enzymes and their inhibitors are indispensable in maintaining physiological homeostasis, these findings suggest that VVP (and PEG1-VVP) may cause an imbalance of human plasma proteinase-proteinase inhibitor systems, thus eliciting an immunocompromised state in the host and facilitating the development of a systemic V. vulnificus infection such as septicemia.

Original languageEnglish
Pages (from-to)959-966
Number of pages8
JournalMicrobiology and Immunology
Volume39
Issue number12
Publication statusPublished - 1995

Fingerprint

Vibrio vulnificus
Metalloproteases
Peptide Hydrolases
Blood Proteins
Sepsis
Classical Complement Pathway
Alternative Complement Pathway
Macroglobulins
Enzyme Inhibitors
Wound Infection
Fibrinogen
Homeostasis
Enzymes

Keywords

  • Metalloprotease
  • Proteinase inhibitor
  • Vibrio vulnificus

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Microbiology

Cite this

@article{4a9055bffd724c43936525d8f1b42610,
title = "Actions of Vibrio vulnificus metalloprotease on human plasma proteinase- proteinase inhibitor systems: A comparative study of native protease with its derivative modified by polyethylene glycol",
abstract = "Vibrio vulnificus, an opportunistic human pathogen causing wound infection and septicemia, produces a metalloprotease (VVP) which is suspected to be a virulent determinant. The interactions of VVP, as well as its derivative (PEG1-VVP) modified with polyethylene glycol, with a variety of human plasma proteins were investigated. We found that native VVP and its derivative were able to act directly on many biologically important human plasma proteins even in the presence of α-macroglobulin, the sole plasma inhibitor of native VVP. The activities of both classical and alternative pathways of the complement cascade system were drastically abolished by incubation with either VVP. Furthermore, these proteases rapidly digested the Aα-chain of human fibrinogen into fragment(s) with no clotting ability. Therefore both VVPs are thought to function as a fibrinogenolytic enzyme, causing delay of the coagulation reaction. VVP and PEG1-VVP were also shown to destroy plasma proteinase inhibitors including α1-proteinase inhibitor, a major inhibitor in human plasma. Because endogenous proteolytic enzymes and their inhibitors are indispensable in maintaining physiological homeostasis, these findings suggest that VVP (and PEG1-VVP) may cause an imbalance of human plasma proteinase-proteinase inhibitor systems, thus eliciting an immunocompromised state in the host and facilitating the development of a systemic V. vulnificus infection such as septicemia.",
keywords = "Metalloprotease, Proteinase inhibitor, Vibrio vulnificus",
author = "Shin-ichi Miyoshi and H. Narukawa and Tomochika, {K. I.} and S. Shinoda",
year = "1995",
language = "English",
volume = "39",
pages = "959--966",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "12",

}

TY - JOUR

T1 - Actions of Vibrio vulnificus metalloprotease on human plasma proteinase- proteinase inhibitor systems

T2 - A comparative study of native protease with its derivative modified by polyethylene glycol

AU - Miyoshi, Shin-ichi

AU - Narukawa, H.

AU - Tomochika, K. I.

AU - Shinoda, S.

PY - 1995

Y1 - 1995

N2 - Vibrio vulnificus, an opportunistic human pathogen causing wound infection and septicemia, produces a metalloprotease (VVP) which is suspected to be a virulent determinant. The interactions of VVP, as well as its derivative (PEG1-VVP) modified with polyethylene glycol, with a variety of human plasma proteins were investigated. We found that native VVP and its derivative were able to act directly on many biologically important human plasma proteins even in the presence of α-macroglobulin, the sole plasma inhibitor of native VVP. The activities of both classical and alternative pathways of the complement cascade system were drastically abolished by incubation with either VVP. Furthermore, these proteases rapidly digested the Aα-chain of human fibrinogen into fragment(s) with no clotting ability. Therefore both VVPs are thought to function as a fibrinogenolytic enzyme, causing delay of the coagulation reaction. VVP and PEG1-VVP were also shown to destroy plasma proteinase inhibitors including α1-proteinase inhibitor, a major inhibitor in human plasma. Because endogenous proteolytic enzymes and their inhibitors are indispensable in maintaining physiological homeostasis, these findings suggest that VVP (and PEG1-VVP) may cause an imbalance of human plasma proteinase-proteinase inhibitor systems, thus eliciting an immunocompromised state in the host and facilitating the development of a systemic V. vulnificus infection such as septicemia.

AB - Vibrio vulnificus, an opportunistic human pathogen causing wound infection and septicemia, produces a metalloprotease (VVP) which is suspected to be a virulent determinant. The interactions of VVP, as well as its derivative (PEG1-VVP) modified with polyethylene glycol, with a variety of human plasma proteins were investigated. We found that native VVP and its derivative were able to act directly on many biologically important human plasma proteins even in the presence of α-macroglobulin, the sole plasma inhibitor of native VVP. The activities of both classical and alternative pathways of the complement cascade system were drastically abolished by incubation with either VVP. Furthermore, these proteases rapidly digested the Aα-chain of human fibrinogen into fragment(s) with no clotting ability. Therefore both VVPs are thought to function as a fibrinogenolytic enzyme, causing delay of the coagulation reaction. VVP and PEG1-VVP were also shown to destroy plasma proteinase inhibitors including α1-proteinase inhibitor, a major inhibitor in human plasma. Because endogenous proteolytic enzymes and their inhibitors are indispensable in maintaining physiological homeostasis, these findings suggest that VVP (and PEG1-VVP) may cause an imbalance of human plasma proteinase-proteinase inhibitor systems, thus eliciting an immunocompromised state in the host and facilitating the development of a systemic V. vulnificus infection such as septicemia.

KW - Metalloprotease

KW - Proteinase inhibitor

KW - Vibrio vulnificus

UR - http://www.scopus.com/inward/record.url?scp=0029595242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029595242&partnerID=8YFLogxK

M3 - Article

C2 - 8789055

AN - SCOPUS:0029595242

VL - 39

SP - 959

EP - 966

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 12

ER -